HealthLynked Corp.
Financial ratios & Valuation

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-175.08-209.45-16.94-1.21-1.83-0.96-2.61-10.18-1.89-20.06-1.47-1.83
Price/Sales ratio
7.187.3111.981.484.713.452.6211.522.843.541.863.45
Price/Book Value ratio
-41.68-62.94-25.57-1.52-3.62-4.8711.9214.7153.0225.2454.18-3.62
Price/Cash Flow ratio
86.521.21K-30.83-1.93-4.51-5.86-7.60-28.12-3.82-4.90-2.47-4.51
Price/Free Cash Flow ratio
86.521.34K-30.32-1.91-4.51-5.84-7.51-27.98-3.80-4.89-2.45-4.51
Price/Earnings Growth ratio
N/A13.96-0.01-0.01-0.01-0.010.03-1.370.080.22-0.08-0.01
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
34.36%42.76%19.83%3.85%-4.76%-5.47%81.02%67.16%92.09%41.04%86.18%-4.76%
Operating Profit Margin
-18.77%-2.92%-60.35%-85.15%-131.56%98.17%-50.08%-54.83%-100.94%-72.55%-131.01%-131.56%
Pretax Profit Margin
-4.10%-3.49%-70.74%-122.69%-256.34%-137.56%-93.83%-113.20%-137.71%-63.15%-118.78%-256.34%
Net Profit Margin
-4.10%-3.49%-70.74%-122.69%-256.34%-356.40%-100.34%-113.20%-150.48%-17.68%-126.99%-256.34%
Effective Tax Rate
N/AN/A-2.66%-3.86%-8.62%-159.07%-6.93%0.00%-9.27%N/A-6.91%-8.62%
Return on Assets
-32.49%-18.06%-417.71%-586.88%-1355.01%-562.45%-76.67%-97.36%-192.45%-23.64%-252.66%-1355.01%
Return On Equity
23.81%30.05%150.97%125.81%197.31%503.86%-455.85%-144.53%-2803.54%-125.78%-302.59%503.86%
Return on Capital Employed
263.95%161.11%185.00%88.24%101.37%-142.83%-97.68%-57.46%-534.69%-222.24%-1079.53%-142.83%
Liquidity Ratios
Current Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A0.61N/A
Quick Ratio
0.590.740.250.140.080.060.061.830.560.210.090.08
Cash ratio
0.100.050.060.020.040.020.031.710.010.100.010.02
Days of Sales Outstanding
34.8942.9627.5519.6618.567.565.183.4221.3014.0610.8010.80
Days of Inventory outstanding
N/A0.00N/AN/A14.806.0629.8516.30151.9614.4155.8814.80
Operating Cycle
34.8942.9627.5519.6633.3713.6235.0419.73173.2728.4758.5533.37
Days of Payables Outstanding
49.2036.3334.7445.7560.8172.02113.3137.01680.6227.20464.4560.81
Cash Conversion Cycle
-14.306.63-7.19-26.08-27.44-58.39-78.27-17.28-507.351.27-439.87-58.39
Debt Ratios
Debt Ratio
1.040.542.192.004.010.970.320.060.160.240.930.97
Debt Equity Ratio
-0.76-0.90-0.79-0.42-0.58-0.871.940.102.351.2813.56-0.58
Long-term Debt to Capitalization
-1.42-1.83-0.35N/AN/AN/A0.340.050.580.350.67N/A
Total Debt to Capitalization
-3.26-9.06-3.82-0.75-1.40-7.000.650.090.700.560.75-1.40
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A-369.24N/A
Cash Flow to Debt Ratio
0.620.05-1.04-1.83-1.37-0.94-0.80-5.10-5.88-4.00-6.93-0.94
Company Equity Multiplier
-0.73-1.66-0.36-0.21-0.14-0.895.941.4814.565.3114.56-0.14
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
0.080.00-0.38-0.76-1.04-0.58-0.34-0.40-0.74-0.72-0.75-1.04
Free Cash Flow / Operating Cash Flow Ratio
10.891.011.001.001.001.011.001.001.001.001.00
Cash Flow Coverage Ratio
0.620.05-1.04-1.83-1.37-0.94-0.80-5.10-5.88-4.00-6.93-0.94
Short Term Coverage Ratio
2.700.20-1.55-1.83-1.37-0.94-1.11-13.04-14.95-7.09-19.97-0.94
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A